ATXS logo

Astria Therapeutics (ATXS) Free Cash Flow

Annual FCF

-$68.47 M
-$24.85 M-56.95%

December 31, 2023


Summary


Performance

ATXS Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherATXScash flowmetrics:

Quarterly FCF

-$27.98 M
-$10.89 M-63.69%

September 30, 2024


Summary


Performance

ATXS Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherATXScash flowmetrics:

TTM FCF

-$94.43 M
-$13.72 M-17.00%

September 30, 2024


Summary


Performance

ATXS TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherATXScash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

ATXS Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-57.0%-96.2%-93.1%
3 y3 years-110.6%-96.2%-93.1%
5 y5 years-191.8%-96.2%-93.1%

ATXS Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-126.9%at low-345.2%+7.5%-213.0%at low
5 y5-year-157.6%at low-345.2%+7.5%-255.4%at low
alltimeall time-317.3%at low-506.1%+7.5%-1945.3%at low

Astria Therapeutics Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$27.98 M(+63.7%)
-$94.43 M(+17.0%)
Jun 2024
-
-$17.10 M(-10.5%)
-$80.71 M(+8.6%)
Mar 2024
-
-$19.09 M(-36.9%)
-$74.31 M(+8.5%)
Dec 2023
-$68.47 M(+57.0%)
-$30.25 M(+112.1%)
-$68.47 M(+40.0%)
Sep 2023
-
-$14.26 M(+33.3%)
-$48.91 M(+8.8%)
Jun 2023
-
-$10.70 M(-19.3%)
-$44.96 M(+1.4%)
Mar 2023
-
-$13.26 M(+24.0%)
-$44.32 M(+1.6%)
Dec 2022
-$43.62 M(+44.6%)
-$10.70 M(+3.8%)
-$43.62 M(+11.2%)
Sep 2022
-
-$10.31 M(+2.4%)
-$39.22 M(+7.0%)
Jun 2022
-
-$10.06 M(-19.9%)
-$36.66 M(+7.8%)
Mar 2022
-
-$12.56 M(+99.8%)
-$33.99 M(+12.7%)
Dec 2021
-$30.17 M(-7.2%)
-$6.29 M(-18.9%)
-$30.17 M(-5.6%)
Sep 2021
-
-$7.75 M(+4.7%)
-$31.96 M(-6.5%)
Jun 2021
-
-$7.40 M(-15.3%)
-$34.18 M(-0.3%)
Mar 2021
-
-$8.74 M(+8.3%)
-$34.27 M(+5.4%)
Dec 2020
-$32.52 M(+22.3%)
-$8.07 M(-19.0%)
-$32.52 M(+0.9%)
Sep 2020
-
-$9.97 M(+33.1%)
-$32.22 M(+12.2%)
Jun 2020
-
-$7.49 M(+7.2%)
-$28.72 M(+6.5%)
Mar 2020
-
-$6.99 M(-10.1%)
-$26.97 M(+1.5%)
Dec 2019
-$26.58 M
-$7.77 M(+20.0%)
-$26.57 M(+10.4%)
Sep 2019
-
-$6.47 M(+12.8%)
-$24.07 M(+3.0%)
Jun 2019
-
-$5.74 M(-12.9%)
-$23.37 M(+0.6%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$6.59 M(+25.0%)
-$23.23 M(-1.0%)
Dec 2018
-$23.46 M(-12.7%)
-$5.27 M(-8.8%)
-$23.46 M(-1.5%)
Sep 2018
-
-$5.78 M(+3.1%)
-$23.83 M(-6.5%)
Jun 2018
-
-$5.60 M(-17.8%)
-$25.49 M(-0.4%)
Mar 2018
-
-$6.82 M(+21.0%)
-$25.60 M(-4.8%)
Dec 2017
-$26.89 M(-19.3%)
-$5.64 M(-24.2%)
-$26.89 M(-8.1%)
Sep 2017
-
-$7.43 M(+30.2%)
-$29.26 M(+1.7%)
Jun 2017
-
-$5.71 M(-29.6%)
-$28.78 M(-10.1%)
Mar 2017
-
-$8.11 M(+1.3%)
-$31.99 M(-4.0%)
Dec 2016
-$33.32 M(+10.3%)
-$8.01 M(+15.3%)
-$33.32 M(-3.2%)
Sep 2016
-
-$6.95 M(-22.2%)
-$34.41 M(-2.6%)
Jun 2016
-
-$8.93 M(-5.4%)
-$35.32 M(+9.0%)
Mar 2016
-
-$9.44 M(+3.7%)
-$32.40 M(+7.2%)
Dec 2015
-$30.21 M(+46.4%)
-$9.10 M(+15.9%)
-$30.21 M(+11.5%)
Sep 2015
-
-$7.85 M(+30.8%)
-$27.10 M(+13.0%)
Jun 2015
-
-$6.00 M(-17.2%)
-$23.98 M(+3.0%)
Mar 2015
-
-$7.25 M(+21.1%)
-$23.28 M(+12.8%)
Dec 2014
-$20.64 M(+25.8%)
-$5.99 M(+26.6%)
-$20.64 M(+40.9%)
Sep 2014
-
-$4.73 M(-10.8%)
-$14.65 M(+47.7%)
Jun 2014
-
-$5.30 M(+14.9%)
-$9.92 M(+114.9%)
Mar 2014
-
-$4.62 M
-$4.62 M
Dec 2013
-$16.41 M
-
-

FAQ

  • What is Astria Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Astria Therapeutics?
  • What is Astria Therapeutics annual FCF year-on-year change?
  • What is Astria Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Astria Therapeutics?
  • What is Astria Therapeutics quarterly FCF year-on-year change?
  • What is Astria Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Astria Therapeutics?
  • What is Astria Therapeutics TTM FCF year-on-year change?

What is Astria Therapeutics annual free cash flow?

The current annual FCF of ATXS is -$68.47 M

What is the all time high annual FCF for Astria Therapeutics?

Astria Therapeutics all-time high annual free cash flow is -$16.41 M

What is Astria Therapeutics annual FCF year-on-year change?

Over the past year, ATXS annual free cash flow has changed by -$24.85 M (-56.95%)

What is Astria Therapeutics quarterly free cash flow?

The current quarterly FCF of ATXS is -$27.98 M

What is the all time high quarterly FCF for Astria Therapeutics?

Astria Therapeutics all-time high quarterly free cash flow is -$4.62 M

What is Astria Therapeutics quarterly FCF year-on-year change?

Over the past year, ATXS quarterly free cash flow has changed by -$13.72 M (-96.22%)

What is Astria Therapeutics TTM free cash flow?

The current TTM FCF of ATXS is -$94.43 M

What is the all time high TTM FCF for Astria Therapeutics?

Astria Therapeutics all-time high TTM free cash flow is -$4.62 M

What is Astria Therapeutics TTM FCF year-on-year change?

Over the past year, ATXS TTM free cash flow has changed by -$45.52 M (-93.06%)